問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

趙敏芳
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2023-02-01 - 2025-12-31

Phase III

Completed
An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)
  • Condition/Disease

    Severe Hypertriglyceridemia

  • Test Drug

    Olezarsen (ISIS 678354)

Participate Sites
7Sites

Recruiting7Sites